Finance

Lists
TEVA:TLV
Teva Pharmaceutical Industries Limited
ILA 12.740,00
+0,87%
(+110,00) 1D
13 ຕ.ລ., 17 ໂມງ 29 ນາທີ 45 ວິນາທີ GMT+3  ·   ILA
All symbols
SymbolPriceChange% Change
Generating top insights for TEVA...
Open
ILA 12.610,00
High
ILA 12.780,00
Low
ILA 12.530,00
Mkt. cap
47,13 ຕື້
Avg. vol.
1,05 ລ້ານ
Volume
980,59 ພັນ
P/E ratio
69,37
52-wk high
ILA 12.780,00
52-wk low
ILA 6.207,00
EPS
ILA 1,84
Shares outstanding
1,17 ຕື້
No. of employees
32 ພັນ
Open
ILA 12.610,00
High
ILA 12.780,00
Low
ILA 12.530,00
Mkt. cap
47,13 ຕື້
Avg. vol.
1,05 ລ້ານ
Volume
980,59 ພັນ
P/E ratio
69,37
52-wk high
ILA 12.780,00
52-wk low
ILA 6.207,00
EPS
ILA 1,84
Shares outstanding
1,17 ຕື້
No. of employees
32 ພັນ
News stories
From web sources and news partners
Chemist+Druggist
Chemist+Druggist
·
6 ຊົ່ວໂມງກ່ອນ
RCPharm cuts ties with Israeli drug company Teva
ad-hoc-news.de
ad-hoc-news.de
·
10 ຊົ່ວໂມງກ່ອນ
JPMorgan raised target for Teva stock to USD 50.00
Profile
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients and, to a lesser extent, contract manufacturing services and an out-licensing platform. Teva's primary branded products include Austedo which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia; and Ajovy, used for the preventive treatment of migraine in adults. Additional branded drugs sold by Teva include Copaxone, Bendeka and Treanda, all of which are primarily sold in the United States. Teva is listed on the Tel Aviv Stock Exchange and the New York Stock Exchange. Its manufacturing facilities are located in Israel, North America, Europe, Australia, and South America. The company is a member of the Pharmaceutical Research and Manufacturers of America. Teva Pharmaceuticals is the largest generic drug manufacturer in the world. Overall, Teva is the 26th largest pharmaceutical company in the world. Teva has a history of legal trouble in relation to collusion and price-fixing to inflate prices for drugs. Wikipedia
About Teva Pharmaceutical Industries Limited
CEORichard Francis
Employees32 ພັນ
Founded13 ກ.ພ. 1944
Headquarters-
SectorPharmaceutical industry
Websiteteva.co.il
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
4,48 ຕື້
4,71 ຕື້
3,98 ຕື້
4,14 ຕື້
Cost of goods sold
2,18 ຕື້
2,06 ຕື້
2,01 ຕື້
1,99 ຕື້
Cost of revenue
2,18 ຕື້
2,06 ຕື້
2,01 ຕື້
1,99 ຕື້
Research and development expenses
256,00 ລ້ານ
267,00 ລ້ານ
222,00 ລ້ານ
970,00 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
973,00 ລ້ານ
1,12 ຕື້
1,00 ຕື້
1,03 ຕື້
Operating expense
1,24 ຕື້
1,37 ຕື້
1,21 ຕື້
1,99 ຕື້
Total operating expenses
3,41 ຕື້
3,43 ຕື້
3,22 ຕື້
3,98 ຕື້
Operating income
1,07 ຕື້
1,28 ຕື້
763,00 ລ້ານ
167,00 ລ້ານ
Other non operating income
-27,00 ລ້ານ
-
-13,00 ລ້ານ
-69,00 ລ້ານ
EBT including unusual items
648,00 ລ້ານ
90,00 ລ້ານ
436,00 ລ້ານ
-455,00 ລ້ານ
EBT excluding unusual items
832,00 ລ້ານ
1,08 ຕື້
547,00 ລ້ານ
-57,00 ລ້ານ
Income tax expense
214,00 ລ້ານ
-390,00 ລ້ານ
67,00 ລ້ານ
121,00 ລ້ານ
Effective tax rate
33,02%
-433,33%
15,37%
-26,59%
Other operating expenses
9,00 ລ້ານ
-17,00 ລ້ານ
-14,00 ລ້ານ
-18,00 ລ້ານ
Net income
433,00 ລ້ານ
480,00 ລ້ານ
369,00 ລ້ານ
-576,00 ລ້ານ
Net profit margin
9,67%
10,19%
9,27%
-13,91%
Earnings per share
0,78
0,96
0,53
0,02
Interest and investment income
-
92,00 ລ້ານ
-
-
Interest expense
-205,00 ລ້ານ
-280,00 ລ້ານ
-191,00 ລ້ານ
-186,00 ລ້ານ
Net interest expenses
-205,00 ລ້ານ
-188,00 ລ້ານ
-191,00 ລ້ານ
-186,00 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
1,32 ຕື້
1,54 ຕື້
1,00 ຕື້
408,00 ລ້ານ
Gain or loss from assets sale
-
-
-8,00 ລ້ານ
-12,00 ລ້ານ
AI content may include mistakes. Learn more
ແອັບຂອງ Google